Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCYZ8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,844
Award facts
- Contract value 100% obligated
- $11,844.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,844.15 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The delivery order, issued on December 5, 2025, is expected to be completed by December 29, 2025, with no set-aside designation applied. DMS Pharmaceutical Group is the sole awardee with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide Department of Defense military healthcare facilities worldwide with comprehensive pharmaceutical supplies. The parent IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. DMS Pharmaceutical Group's established track record supplying branded and generic prescription drugs, biologics, and specialized pharmaceuticals positions it as a critical vendor within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCYZ8?
SPE2DR26FCYZ8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FCYZ8 worth?
The government has obligated $11,844 on SPE2DR26FCYZ8.
Is contract SPE2DR26FCYZ8 an order under another contract?
Yes. SPE2DR26FCYZ8 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYZ8 competed?
The extent of competition for SPE2DR26FCYZ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award